BERGAMI, MARIA FIORELLA
 Distribuzione geografica
Continente #
NA - Nord America 49
EU - Europa 40
AS - Asia 1
Totale 90
Nazione #
US - Stati Uniti d'America 49
IE - Irlanda 30
FI - Finlandia 5
DE - Germania 2
BE - Belgio 1
IL - Israele 1
IT - Italia 1
UA - Ucraina 1
Totale 90
Città #
Dublin 26
Chandler 21
Helsinki 5
Lawrence 3
Medford 3
Princeton 3
Ashburn 2
Brussels 1
Haifa 1
Rovello Porro 1
San Diego 1
San Francisco 1
Totale 68
Nome #
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up 40
Immunogenicity and safety after the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors on active treatment: a prospective cohort study 30
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study 24
Totale 94
Categoria #
all - tutte 405
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 405


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202220 0 0 0 0 0 0 1 1 0 7 2 9
2022/202361 4 8 0 7 4 3 0 1 31 0 3 0
2023/202413 4 4 1 2 1 1 0 0 0 0 0 0
Totale 94